Molecular mechanism of miRNA regulating PD-L1 expression

被引:0
|
作者
Zhao, Wenxin [1 ,2 ]
Li, Xiaolan [1 ,2 ]
Ren, Qunli [1 ,2 ]
Wang, Qian [1 ,2 ]
Liao, Chengcheng [2 ]
Ding, Tianhao [2 ]
Li, Ping [1 ]
Liu, Jianguo [2 ]
机构
[1] Zunyi Med Univ, Microbial Resources & Drug Dev Key Lab Guizhou Ter, Sch Stomatol, Zunyi 563000, Peoples R China
[2] Zunyi Med Univ, Sch Clin Med, Zunyi 563000, Peoples R China
来源
GENE REPORTS | 2023年 / 31卷
关键词
PD-L1; miRNA; Immune checkpoint; Molecular regulation; Tumor suppressor gene; BREAST-CANCER; TARGETS PD-L1;
D O I
10.1016/j.genrep.2023.101763
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
PD-L1 (programmed death-ligand 1) binding to PD-1 (programmed cell death protein 1) reduces the proliferation of PD-1-positive cells, inhibits their cytokine secretion, and induces apoptosis. miRNA (microRNA) as an important regulator of gene expression, affects the performance of gene function. Similarly, the expression of PDL1 is also regulated by miRNA. miRNAs usually negatively regulate gene expression, however, is there positive regulation? We reviewed the molecular mechanisms of the positive and negative regulation of PD-L1 expression by miRNAs. miRNAs mainly indirectly and positively regulate PD-L1 expression through the regulation of tumor suppressor genes PTEN (phosphatase and tensin homolog) and LATS2 (large tumor suppressor kinase 2), oncogene YAP1 (Yes1 associated transcriptional regulator), DNA damage response protein Ku80 (80-kilodalton subunit of the Ku heterodimer protein), etc., while negative regulation is mainly achieved by miRNAs directly binding to the 3 & PRIME;-UTR (3 & PRIME; untranslated region) of PD-L1 mRNA. And this negative regulation can also be reversed by the negative regulation of miRNAs by RNA-binding protein LIN28 (protein lin-28) or circRNAs (circular RNA) such as cire0000284 and circ-CPA4. The revealing of this mechanism provides more references and strategies for immune checkpoint therapy of tumors.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy
    Palicelli, Andrea
    Bonacini, Martina
    Croci, Stefania
    Bisagni, Alessandra
    Zanetti, Eleonora
    De Biase, Dario
    Sanguedolce, Francesca
    Ragazzi, Moira
    Zanelli, Magda
    Chaux, Alcides
    Canete-Portillo, Sofia
    Bonasoni, Maria Paola
    Ascani, Stefano
    De Leo, Antonio
    Gandhi, Jatin
    Tafuni, Alessandro
    Melli, Beatrice
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [22] Regulatory mechanisms of PD-L1 expression in cancer cells
    Shi, Yongyu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (10) : 1481 - 1489
  • [23] Imaging PD-L1 Expression with ImmunoPET
    Truillet, Charles
    Oh, Hsueh Ling J.
    Yeo, Siok Ping
    Lee, Chia-Yin
    Huynh, Loc T.
    Wei, Junnian
    Parker, Matthew F. L.
    Blakely, Collin
    Sevillano, Natalia
    Wang, Yun-Hua
    Shen, Yuqin S.
    Olivas, Victor
    Jami, Khaled. M.
    Moroz, Anna
    Jego, Benoit
    Jaumain, Emilie
    Fong, Lawrence
    Craik, Charles S.
    Chang, Albert J.
    Bivona, Trever G.
    Wang, Cheng-I
    Evans, Michael J.
    BIOCONJUGATE CHEMISTRY, 2018, 29 (01) : 96 - 103
  • [24] Glial Cell Expression of PD-L1
    Chauhan, Priyanka
    Lokensgard, James R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
  • [25] PD-L1 expression in breast cancer brain metastases
    Chehade, Rania
    Qazi, Maleeha A.
    Ennis, Marguerite
    Sahgal, Arjun
    Das, Sunit
    Nofech-Mozes, Sharon
    Jerzak, Katarzyna J.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [26] Regulatory mechanisms of PD-L1 expression in cancer cells
    Yongyu Shi
    Cancer Immunology, Immunotherapy, 2018, 67 : 1481 - 1489
  • [27] PD-L1 Expression in Lung Cancer
    Yu, Hui
    Boyle, Theresa A.
    Zhou, Caicun
    Rimm, David L.
    Hirsch, Fred R.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : 964 - 975
  • [28] The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer
    Yadav, Ritu
    Khatkar, Rinku
    Yap, Kenneth C-H
    Kang, Chloe Yun-Hui
    Lyu, Juncheng
    Singh, Rahul Kumar
    Mandal, Surojit
    Mohanta, Adrija
    Lam, Hiu Yan
    Okina, Elena
    Kumar, Rajiv Ranjan
    Uttam, Vivek
    Sharma, Uttam
    Jain, Manju
    Prakash, Hridayesh
    Tuli, Hardeep Singh
    Kumar, Alan Prem
    Jain, Aklank
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [29] PD-L1 expression in sebaceous carcinomas
    Maelle Saliba
    Muhammad Shaheen
    Rana El Hajj
    Fatmeh Abbas
    Shaarif Bashir
    Umer Nisar Sheikh
    Rami Mahfouz
    Asif Loya
    Ibrahim Khalifeh
    Cancer Immunology, Immunotherapy, 2021, 70 : 1907 - 1915
  • [30] PD-L1 Expression in Ampullary Adenocarcinoma
    Siddiqui, Saima Haleem
    Kumari, Niraj
    Mishra, Shravan
    Radha, Paturu
    Mohindra, Samir
    Singh, Rajneesh K.
    Krishnani, Narendra
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2024, 32 (02) : 263 - 272